BioPortfolio - Wellstat Biologics Corporation
Wellstat Biologics Corporation - Entry on Bioportfolio's Biocorporate Database. ... administration of PV701, an oncolytic Newcastle disease virus. ...
http://www.bioportfolio.com/biocorporate/31943-Wellstat_Biol...
|
Replicating Oncolytic Virus Therapeutics - Third International ...
PV-701 (Wellstat Biologics Corp) is a replication-competent. virus derived from a vaccine strain of Newcastle disease. virus, a paramyxovirus that normally ...
http://www.biomedcentral.com/content/pdf/cd-597188.pdf...
|
BioPortfolio - Wellstat Biologics Corporation - Profile
Phase 1 clinical experience using intravenous administration of PV701, an oncolytic Newcastle disease · virus. PV701 is a naturally-attenuated, ...
http://www.bioportfolio.com/biocorporate/31943-Wellstat+Biol...
|
Phase 1 clinical experience using intravenous admi...[Curr Cancer ...
... administration of PV701, an oncolytic Newcastle disease virus. ... Wellstat Biologics Corporation has evaluated the effects of dose, schedule, ...
http://www.ncbi.nlm.nih.gov/pubmed/17346107...
|
Overview of phase I studies of intravenous administration of PV701 ...
Keywords Intravenous virotherapy, Newcastle disease virus,. oncolytic virus, phase I, PV701. Introduction. PV701 (Wellstat Biologics Corp) is a highly ...
http://www.biomedcentral.com/content/pdf/cd-516870.pdf...
|
Overview of phase I studies of intravenous administration of PV701 ...
Wellstat Biologics Corporation, 930 Clopper Road, Gaithersburg, MD 20878, ... Newcastle disease virus/genetics Newcastle disease virus/metabolism* ...
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&d...
|
Molecular Therapy - Abstract of article: 55. Translating ...
1Department of Viral Therapeutics, Wellstat Biologics Corporation, Gaithersburg, MD ... non-recombinant oncolytic Newcastle disease virus that is naturally ...
http://www.nature.com/mt/journal/v13/n1s/abs/mt2006196a.html...
|
Gene Therapy of Cancer - 11th International Conference Gayathri Devi
replication-competent strain of Newcastle disease virus,. featured both in Robert Lorence's (Wellstat Biologics Corp,. USA) oral presentation of a phase I
...
http://www.biomedcentral.com/content/pdf/cd-478336.pdf...
|
Nature Clinical Practice Oncology | Clinical trial results with ...
Newcastle disease virus. The NDV strain PV701 (Wellstat Biologics, Gaithersburg, MD) was tested in patients with metastatic solid tumors32 (Table 3). ...
http://www.nature.com/ncponc/journal/v4/n2/full/ncponc0736.h...
|
Overview of phase I studies of intravenous adminis...[Curr Opin ...
Wellstat Biologics Corporation, 930 Clopper Road, Gaithersburg, MD 20878, ... oncolytic strain of Newcastle disease virus that displays preclinical ...
http://www.ncbi.nlm.nih.gov/pubmed/14755888...
|
